Prospective Randomized Trial Comparing Running Intradermal and Interrupted Transdermal Sutures for Skin Closure After Brain Tumor Surgery

What this Trial Is About

Researchers are comparing two common methods of closing the skin after surgery for brain tumors. Proper skin closure is crucial for wound healing and can affect how soon further treatments like radiotherapy or chemotherapy can begin. The study focuses on patients undergoing craniotomy for supratentorial intracranial tumors and aims to provide scientific evidence to guide the choice of suturing techniques in neurosurgery. Participants will receive one of two skin closure methods after tumor surgery: running absorbable intradermal sutures or interrupted non-absorbable transdermal sutures. Both techniques are widely used and considered safe, but this study will evaluate their effects on wound healing and related complications. The study is randomized and participants will be observed for 90 days after surgery. During the study, researchers will monitor wound healing complications such as infections, wound edge separation, and cerebrospinal fluid leakage. They will assess the aesthetic quality of healing from both patient and observer perspectives and record pain or discomfort related to suture removal. Additional interventions, infection rates, and costs of materials will also be tracked. Follow-up visits will occur up to 90 days postoperatively to evaluate outcomes and safety.

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures